English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduSurvival rates for breast cancer continue to improve due to advances in diagnosis and treatment, leading to increasing emphasis on reducing the long-term toxicity of cancer treatment, including radiotherapy.
Prior to this study, all patients treated with proton postmastectomy radiotherapy (PMRT) had received a conventional 25- to 30-day course delivered five days per week over five to six weeks. The researchers hoped to demonstrate that condensing the course of proton beam therapy, a form of particle therapy that could spare the heart and lungs from radiation damage, may result in a similar side effect profile.
Eighty-two patients with indications for PMRT, many of whom had prior breast reconstruction, were randomized to either conventional fractionation (fractions of radiation dose) administered in 25 days, or a condensed 15-day hypofractionated schedule. With hypofractionation, a larger dose of radiotherapy is delivered with each treatment, allowing all radiotherapy to be completed in just three weeks. The investigators found that both conventional and hypofractionated proton therapy resulted in excellent control of the cancer while sparing surrounding normal tissue. Further, complication rates were comparable between the two study groups.
“The study provides the first prospective data supporting the use of shorter-course proton PMRT, including in patients with immediate breast reconstruction, and the first mature results of a randomized trial in the field of breast particle therapy,” says Robert Mutter, M.D., a radiation oncologist and physician-scientist at Mayo Clinic Comprehensive Cancer Center. “We can now consider the option of 15 days of therapy with patients based on the similar treatment outcomes observed as the longer conventional course. Of note, the short course actually resulted in reduced skin side effects during and after treatment.”
Importantly, the researchers noted that the new schedule spares patients additional inconvenience, cost, and other burdens associated with the longer regimen. As there are a limited number of proton therapy facilities in the United States and the world, Dr. Mutter adds that demonstrating the safety and feasibility of the shorter treatment course could result in greater access to proton beam technology for difficult-to-treat breast cancer cases.
The researchers say additional investigation into the optimal PMRT dose and fractionation is warranted. The team plans additional research, investigating the delivery of PMRT in as few as five days.
“Ultimately, our goal is to personalize radiotherapy based on tumor biology,” Dr. Mutter says. “We want to identify the best possible radiotherapy schedules or drug-radiotherapy combinations to eliminate cancer while minimizing side effects.”
The research was funded by a grant from the National Cancer Institute, Mayo Clinic, and a gift from Lawrence and Marilyn Matteson. For a full list of funding, authors, and conflicts of interest, see the paper.
Mayo Clinic is expanding its proton beam therapy services in Rochester, Minnesota, with a $200 million facility expansion project expected to open in 2027. Mayo Clinic opened its first Minnesota proton facility in 2015. In 2016, Mayo Clinic opened the Southwest’s first proton therapy facility at its Arizona site. Now, construction is underway on a new, 200,000-square-foot integrated oncology building on Mayo Clinic’s campus in Florida where proton beam therapy will be delivered to patients when available in 2026. The facility also will allow Mayo Clinic researchers to study carbon ion therapy in clinical trials as a potential treatment.
###
About Mayo Clinic Comprehensive Cancer Center
Designated as a comprehensive cancer center by the National Cancer Institute, Mayo Clinic Comprehensive Cancer Center is defining new boundaries in possibility, focusing on patient-centered care, developing novel treatments, training future generations of cancer experts, and bringing cancer research to communities. At Mayo Clinic Comprehensive Cancer Center, a culture of innovation and collaboration is driving research breakthroughs that are changing approaches to cancer prevention, screening, and treatment and improving the lives of cancer survivors.
About Mayo Clinic
Mayo Clinic is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the Mayo Clinic News Network for additional Mayo Clinic news.
